Literature DB >> 17681359

Hospital-based surveillance of meningococcal meningitis in Salvador, Brazil.

Soraia M Cordeiro1, Alan B Neves, Cássio T Ribeiro, Maya L Petersen, Edilane L Gouveia, Guilherme S Ribeiro, Tatiana S Lôbo, Joice N Reis, Kátia M Salgado, Mitermayer G Reis, Albert I Ko.   

Abstract

This study aimed to describe the clinical, epidemiological and microbiological features of meningococcal meningitis in Salvador, Brazil. Between February 1996 and January 2001, a hospital-based surveillance prospectively identified cases of culture-positive meningococcal meningitis. Demographic and clinical data were collected through interview and medical chart review. Antisera and monoclonal antibodies were used to determine the serogroup and serotype:serosubtype of the isolates, respectively. Surveillance identified a total of 408 cases of meningococcal meningitis, with a case fatality rate of 8% (32/397). The mean annual incidence for the 304 culture-positive cases residing in metropolitan Salvador was 1.71 cases per 100,000 population. Infants <1 year old presented the highest incidence (14.7 cases per 100,000 population). Of the 377 serogrouped isolates, 82%, 16%, 2% and 0.3% were serogroups B, C, W135 and Y, respectively. A single serotype:serosubtype (4,7:P1.19,15) accounted for 64% of all cases. Continued surveillance is necessary to characterise strains and to define future prevention and control strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17681359      PMCID: PMC2042916          DOI: 10.1016/j.trstmh.2007.06.012

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  30 in total

Review 1.  Meningococcal disease.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; T Popovic; J M Hughes
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

2.  Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.

Authors:  M Diermayer; K Hedberg; F Hoesly; M Fischer; B Perkins; M Reeves; D Fleming
Journal:  JAMA       Date:  1999-04-28       Impact factor: 56.272

3.  A universal vaccine for serogroup B meningococcus.

Authors:  Marzia M Giuliani; Jeannette Adu-Bobie; Maurizio Comanducci; Beatrice Aricò; Silvana Savino; Laura Santini; Brunella Brunelli; Stefania Bambini; Alessia Biolchi; Barbara Capecchi; Elena Cartocci; Laura Ciucchi; Federica Di Marcello; Francesca Ferlicca; Barbara Galli; Enrico Luzzi; Vega Masignani; Davide Serruto; Daniele Veggi; Mario Contorni; Maurizio Morandi; Alessandro Bartalesi; Vanda Cinotti; Donatella Mannucci; Francesca Titta; Elisa Ovidi; Jo Anne Welsch; Dan Granoff; Rino Rappuoli; Mariagrazia Pizza
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-06       Impact factor: 11.205

Review 4.  Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience.

Authors:  E A Kirsch; R P Barton; L Kitchen; B P Giroir
Journal:  Pediatr Infect Dis J       Date:  1996-11       Impact factor: 2.129

5.  Intercontinental spread of Neisseria meningitidis clones of the ET-5 complex.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Antonie Van Leeuwenhoek       Date:  1987       Impact factor: 2.271

6.  Invasive meningococcal disease in children in Greece: comparison of serogroup A disease with disease caused by other serogroups.

Authors:  M N Tsolia; M Theodoridou; G Tzanakaki; V Vlachou; G Mostrou; F Stripeli; P Kalabalikis; A Pangalis; D Kafetzis; J Kremastinou; A Konstantopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-07       Impact factor: 3.267

7.  Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.

Authors:  Caroline L Trotter; Nick J Andrews; Edward B Kaczmarski; Elizabeth Miller; Mary E Ramsay
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

Review 8.  Meningococcal disease: still with us.

Authors:  H Peltola
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

9.  Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.

Authors:  G V Sierra; H C Campa; N M Varcacel; I L Garcia; P L Izquierdo; P F Sotolongo; G V Casanueva; C O Rico; C R Rodriguez; M H Terry
Journal:  NIPH Ann       Date:  1991-12

10.  Meningococcal serotypes and serogroup B disease in north-west Europe.

Authors:  J T Poolman; I Lind; K Jónsdóttir; L O Frøholm; D M Jones; H C Zanen
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

View more
  6 in total

Review 1.  An epidemiological review of changes in meningococcal biology during the last 100 years.

Authors:  Anne Abio; Keith R Neal; Charles R Beck
Journal:  Pathog Glob Health       Date:  2013-12-19       Impact factor: 2.894

2.  Bacterial Meningitis in Brazil: Baseline Epidemiologic Assessment of the Decade Prior to the Introduction of Pneumococcal and Meningococcal Vaccines.

Authors:  Luciano Cesar Pontes Azevedo; Cristiana M Toscano; Ana Luiza Bierrenbach
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

Review 3.  The epidemiology of meningococcal disease in Latin America 1945-2010: an unpredictable and changing landscape.

Authors:  M A P Sáfadi; S González-Ayala; A Jäkel; H Wieffer; C Moreno; A Vyse
Journal:  Epidemiol Infect       Date:  2012-08-09       Impact factor: 2.451

4.  Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil.

Authors:  Ivano de Filippis; Ana Paula S de Lemos; Jessica B Hostetler; Kurt Wollenberg; Claudio T Sacchi; Julie C Dunning Hotopp; Lee H Harrison; Margaret C Bash; D Rebecca Prevots
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

5.  Effectiveness of meningococcal C conjugate vaccine in Salvador, Brazil: a case-control study.

Authors:  Cristiane Wanderley Cardoso; Guilherme Sousa Ribeiro; Mitermayer Galvão Reis; Brendan Flannery; Joice Neves Reis
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

6.  Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis.

Authors:  Henry M Wu; Soraia M Cordeiro; Brian H Harcourt; Mariadaglorias Carvalho; Jailton Azevedo; Tainara Q Oliveira; Mariela C Leite; Katia Salgado; Mitermayer G Reis; Brian D Plikaytis; Thomas A Clark; Leonard W Mayer; Albert I Ko; Stacey W Martin; Joice N Reis
Journal:  BMC Infect Dis       Date:  2013-01-22       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.